|
1
|
Ensley JF, Youssef E, Kim H and Yoo G:
Locally advanced nasopharyngeal cancer. Curr Treat Options Oncol.
2:15–23. 2001. View Article : Google Scholar
|
|
2
|
Chan AT, Teo PM and Johnson PJ:
Nasopharyngeal carcinoma. Ann Oncol. 13:1007–1015. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gius D and Coleman CN: Treatment of
nasopharyngeal cancer: raising the ‘Barr’. J Natl Cancer Inst.
94:1594–1595. 2002.
|
|
4
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar
|
|
5
|
Wee J: Nasopharyngeal cancer: a promising
future. Lancet Oncol. 13:116–118. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kwong DL, Sham JS, Au GK, et al:
Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma:
a factorial study. J Clin Oncol. 22:2643–2653. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kam MK, Leung SF, Zee B, et al:
Prospective randomized study of intensity-modulated radiotherapy on
salivary gland function in early-stage nasopharyngeal carcinoma
patients. J Clin Oncol. 25:4873–4879. 2007. View Article : Google Scholar
|
|
8
|
Wee J, Tan EH, Tai BC, et al: Randomized
trial of radiotherapy versus concurrent chemoradiotherapy followed
by adjuvant chemotherapy in patients with American Joint Committee
on Cancer/International Union against cancer stage III and IV
nasopharyngeal cancer of the endemic variety. J Clin Oncol.
23:6730–6738. 2005. View Article : Google Scholar
|
|
9
|
Al-Sarraf M, LeBlanc M, Giri PG, et al:
Chemoradiotherapy versus radiotherapy in patients with advanced
nasopharyngeal cancer: phase III randomized Intergroup study 0099.
J Clin Oncol. 16:1310–1317. 1998.PubMed/NCBI
|
|
10
|
Chan AT, Leung SF, Ngan RK, et al: Overall
survival after concurrent cisplatin-radiotherapy compared with
radiotherapy alone in locoregionally advanced nasopharyngeal
carcinoma. J Natl Cancer Inst. 97:536–539. 2005. View Article : Google Scholar
|
|
11
|
Zhang L, Zhao C, Peng PJ, et al: Phase III
study comparing standard radiotherapy with or without weekly
oxaliplatin in treatment of locoregionally advanced nasopharyngeal
carcinoma: preliminary results. J Clin Oncol. 23:8461–8468. 2005.
View Article : Google Scholar
|
|
12
|
Lin JC, Jan JS, Hsu CY, Liang WM, Jiang RS
and Wang WY: Phase III study of concurrent chemoradiotherapy versus
radiotherapy alone for advanced nasopharyngeal carcinoma: positive
effect on overall and progression-free survival. J Clin Oncol.
21:631–637. 2003. View Article : Google Scholar
|
|
13
|
Chan AT, Teo PM, Ngan RK, et al:
Concurrent chemotherapyradiotherapy compared with radiotherapy
alone in locoregionally advanced nasopharyngeal carcinoma:
progression-free survival analysis of a phase III randomized trial.
J Clin Oncol. 20:2038–2044. 2002. View Article : Google Scholar
|
|
14
|
Lee NY, Zhang Q, Pfister DG, et al:
Addition of bevacizumab to standard chemoradiation for
locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a
phase 2 multi-institutional trial. Lancet Oncol. 13:172–180. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Al-Amro A, Al-Rajhi N, Khafaga Y, et al:
Neoadjuvant chemotherapy followed by concurrent chemoradiation
therapy in locally advanced nasopharyngeal carcinoma. Int J Radiat
Oncol Biol Phys. 62:508–513. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Langendijk JA, Leemans CR, Buter J,
Berkhof J and Slotman BJ: The additional value of chemotherapy to
radiotherapy in locally advanced nasopharyngeal carcinoma: a
meta-analysis of the published literature. J Clin Oncol.
22:4604–4612. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee N, Harris J, Garden AS, et al:
Intensity-modulated radiation therapy with or without chemotherapy
for nasopharyngeal carcinoma: radiation therapy oncology group
phase II trial 0225. J Clin Oncol. 27:3684–3690. 2009. View Article : Google Scholar
|
|
18
|
Koom WS, Kim TH, Shin KH, et al: SMART
(simultaneous modulated accelerated radiotherapy) for locally
advanced nasopharyngeal carcinomas. Head & neck. 30:159–169.
2008.PubMed/NCBI
|
|
19
|
Lee SW, Back GM, Yi BY, et al: Preliminary
results of a phase I/II study of simultaneous modulated accelerated
radiotherapy for nondisseminated nasopharyngeal carcinoma. Int J
Cancer. 65:152–160. 2006.PubMed/NCBI
|
|
20
|
Chan AT: Head and neck cancer: treatment
of nasopharyngeal cancer. Ann Oncol. 16(Suppl 2): ii265–268.
2005.PubMed/NCBI
|
|
21
|
Licitra L, Bossi P, Locati L and Zunino F:
Cisplatin and fluorouracil concurrent to radiotherapy in
nasopharyngeal cancer: is the schedule compatible? J Clin Oncol.
22:377author reply 377–378, 2004.
|
|
22
|
Chua DT, Ma J, Sham JS, et al: Long-term
survival after cisplatin-based induction chemotherapy and
radiotherapy for nasopharyngeal carcinoma: a pooled data analysis
of two phase III trials. J Clin Oncol. 23:1118–1124. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hui EP, Ma BB, Leung SF, et al: Randomized
phase II trial of concurrent cisplatin-radiotherapy with or without
neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal
carcinoma. J Clin Oncol. 27:242–249. 2009. View Article : Google Scholar
|
|
24
|
Hong RL, Ting LL, Ko JY, et al: Induction
chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil,
and leucovorin followed by radiotherapy in the treatment of
locoregionally advanced nasopharyngeal carcinoma. J Clin Oncol.
19:4305–4313. 2001.
|
|
25
|
Chan AT, Ma BB, Lo YM, et al: Phase II
study of neoadjuvant carboplatin and paclitaxel followed by
radiotherapy and concurrent cisplatin in patients with
locoregionally advanced nasopharyngeal carcinoma: therapeutic
monitoring with plasma Epstein-Barr virus DNA. J Clin Oncol.
22:3053–3060. 2004. View Article : Google Scholar
|
|
26
|
Cheng SH, Tsai SY, Yen KL, et al:
Concomitant radiotherapy and chemotherapy for early-stage
nasopharyngeal carcinoma. J Clin Oncol. 18:2040–2045.
2000.PubMed/NCBI
|
|
27
|
Lee TF, Chao PJ, Ting HM, et al:
Comparative analysis of SmartArc-based dual arc
volumetric-modulated arc radio-therapy (VMAT) versus
intensity-modulated radiotherapy (IMRT) for nasopharyngeal
carcinoma. J Appl Clin Med Phys. 12:35872011.PubMed/NCBI
|
|
28
|
Cheng JC, Chao KS and Low D: Comparison of
intensity modulated radiation therapy (IMRT) treatment techniques
for nasopharyngeal carcinoma. Int J Cancer. 96:126–131. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kristensen CA, Kjaer-Kristoffersen F,
Sapru W, Berthelsen AK, Loft A and Specht L: Nasopharyngeal
carcinoma. Treatment planning with IMRT and 3D conformal
radiotherapy. Acta Oncologica. 46:214–220. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee N, Xia P, Quivey JM, et al:
Intensity-modulated radiotherapy in the treatment of nasopharyngeal
carcinoma: an update of the UCSF experience. Int J Radiat Oncol
Biol Phys. 53:12–22. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lauve A, Morris M, Schmidt-Ullrich R, et
al: Simultaneous integrated boost intensity-modulated radiotherapy
for locally advanced head-and-neck squamous cell carcinomas:
II--clinical results. Int J Radiat Oncol Biol Phys. 60:374–387.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xiao WW, Huang SM, Han F, et al: Local
control, survival, and late toxicities of locally advanced
nasopharyngeal carcinoma treated by simultaneous modulated
accelerated radiotherapy combined with cisplatin concurrent
chemotherapy: long-term results of a phase 2 study. Cancer.
117:1874–1883. 2011. View Article : Google Scholar
|
|
33
|
Lee VH, Ng SC, Leung TW, Au GK and Kwong
DL: Dosimetric predictors of radiation-induced acute nausea and
vomiting in IMRT for nasopharyngeal cancer. Int J Cancer.
2012.PubMed/NCBI
|
|
34
|
Park SH, Park HC, Park SW, et al:
Multi-institutional comparison of intensity modulated radiation
therapy (IMRT) planning strategies and planning results for
nasopharyngeal cancer. J Korean Med Sci. 24:248–255. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen QY, Wen YF, Guo L, et al: Concurrent
chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal
carcinoma: phase III randomized trial. J Natl Cancer Inst.
103:1761–1770. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen L, Hu CS, Chen XZ, et al: Concurrent
chemoradiotherapy plus adjuvant chemotherapy versus concurrent
chemoradiotherapy alone in patients with locoregionally advanced
nasopharyngeal carcinoma: a phase 3 multicentre randomised
controlled trial. Lancet Oncol. 13:163–171. 2012. View Article : Google Scholar
|
|
37
|
Lee AW, Tung SY, Chua DT, et al:
Randomized trial of radiotherapy plus concurrent-adjuvant
chemotherapy vs radiotherapy alone for regionally advanced
nasopharyngeal carcinoma. J Natl Cancer Inst. 102:1188–1198. 2010.
View Article : Google Scholar : PubMed/NCBI
|
